Showing results (811-820 of 9,109) with videos related to
Sort By:
Pageof 911
Cancer Medicine|December 3, 2014
Fruits, vegetables, and bladder cancer risk: a systematic review and meta-analysisAna R Vieira, Snieguole Vingeliene, Doris S M Chan, et al.Cancer Medicine|October 31, 2014
Discrimination of p53 immunohistochemistry-positive tumors by its staining pattern in gastric cancerKoji Ando, Eiji Oki, Hiroshi Saeki, et al.Cancer Medicine|October 31, 2014
Vismodegib, an antagonist of hedgehog signaling, directly alters taste molecular signaling in taste budsHyekyung Yang, Wei-Na Cong, Jeong Seon Yoon, et al.Cancer Medicine|October 31, 2014
Tobacco smoking, polymorphisms in carcinogen metabolism enzyme genes, and risk of localized and advanced prostate cancer: results from the California Collaborative Prostate Cancer StudyAhva Shahabi, Román Corral, Chelsea Catsburg, et al.Cancer Medicine|October 10, 2014
A retrospective analysis of cross-reacting cetuximab IgE antibody and its association with severe infusion reactionsSabine Maier, Christine H Chung, Michael Morse, et al.Cancer Medicine|October 16, 2014
δEF1 associates with DNMT1 and maintains DNA methylation of the E-cadherin promoter in breast cancer cellsAkihiko Fukagawa, Hiroki Ishii, Keiji Miyazawa, et al.Cancer Medicine|November 19, 2020
MiR-362 suppresses cervical cancer progression via directly targeting BAP31 and activating TGFβ/Smad pathwayShuya Yang, Yuanjie Sun, Dongbo Jiang, et al.Cancer Medicine|November 19, 2020
Clinical characteristics and management of immune checkpoint inhibitor-related pneumonitis: A single-institution retrospective studyHanping Wang, Yanwei Zhao, Xiaotong Zhang, et al.Cancer Medicine|November 21, 2020
Older cancer patients and COVID-19 outbreak: Practical considerations and recommendationsAntonella Brunello, Antonella Galiano, Silvia Finotto, et al.Cancer Medicine|November 7, 2020
Characteristics and risk factors for microbial infections during cancer immune checkpoint therapyYada Kanjanapan, Desmond YipPageof 911